Mr Aselage is currently senior vice president of global commercial development at BioMarin Pharmaceuticals. Prior to joining BioMarin, he held the position of executive vice president of global commercial operations at Cell Therapeutics.
Prior to Cell Therapeutics, Mr Aselage served as senior vice president of North American sales and marketing for Sangstat. He has also held a variety of other positions at biotechnology and pharmaceutical companies, including Advanced Tissue Sciences, Rhone-Poulenc Rorer Pharmaceuticals, Genentech and Bristol Laboratories.
Stephen Dilly, president and CEO of APT Pharmaceuticals, said: “Steve brings decades of experience in the commercialization of new products in the biopharmaceutical industry. We now have a board with deep experience in all critical functional areas to support our team as we successfully develop and launch products for serious lung diseases.”